[The polymyositis-dermatomyositis complex: current studies of the etiopathogenesis and notes on therapy].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001323:Autoantibodies / Q000032:analysis; D001327:Autoimmune Diseases; D001424:Bacterial Infections / Q000150:complications*; D003882:Dermatomyositis / Q000188:drug therapy / Q000209:etiology*; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D009132:Muscles / Q000276:immunology; D009220:Myositis / Q000188:drug therapy / Q000209:etiology; D009560:Niridazole / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology; D014777:Virus Diseases / Q000150:complications*
D000305:Adrenal Cortex Hormones; D001323:Autoantibodies; D006680:HLA Antigens; D007166:Immunosuppressive Agents; D007978:Levamisole; D009560:Niridazole
Il complesso polimiosite-dermatomiosite: aggiornamento in tema di eziopatogenesi e note di terapia.